Integrated DNA Technologies

Integrated DNA Technologies (IDT) is a well-established, revenue-generating private company and a foundational supplier in the life sciences tools sector. It operates a robust technology and manufacturing platform centered on high-throughput, high-quality nucleic acid synthesis, which supports a diverse product line for genomics research, molecular diagnostics, and therapeutic development. The company has strategically expanded from its core oligo business into high-growth areas like CRISPR gene editing reagents, NGS library preparation, and GMP manufacturing for clinical applications. As a subsidiary of Danaher Corporation, IDT benefits from significant operational and financial resources, positioning it as a dominant and integrated player in the genomics supply chain.

Proprietary high-throughput nucleic acid synthesis and purification platform supporting custom oligo manufacturing, CRISPR gene editing reagents (Alt-R system), NGS library prep (xGen), and qPCR/dPCR assays (PrimeTime).

IDT competes in a crowded life science tools market. Primary competitors include Thermo Fisher Scientific (Affymetrix, Invitrogen), Merck KGaA (Sigma-Aldrich), and Agilent Technologies in broad-based oligo and reagent supply. In NGS and CRISPR, it faces specialists like Twist Bioscience (gene synthesis), Editas Medicine & Intellia Therapeutics (therapeutic-focused tools), and numerous NGS panel providers. Its scale, quality reputation, and Danaher ownership are key differentiators.